Luke Sergott
Stock Analyst at Barclays
(2.19)
# 2,839
Out of 4,970 analysts
308
Total ratings
42.11%
Success rate
-4.6%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Equal-Weight | $125 | $128.48 | -2.71% | 11 | Aug 29, 2025 | |
| NTRA Natera | Maintains: Overweight | $190 → $210 | $166.56 | +26.08% | 4 | Aug 8, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $13 → $15 | $13.57 | +10.54% | 13 | Aug 8, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $5 → $6 | $10.51 | -42.91% | 11 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $65 → $55 | $51.41 | +6.98% | 6 | Aug 7, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $155 → $165 | $162.31 | +1.66% | 8 | Aug 7, 2025 | |
| BRKR Bruker | Maintains: Overweight | $46 → $43 | $29.79 | +44.34% | 5 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Overweight | $15 → $13 | $13.19 | -1.44% | 25 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Underweight | $85 → $90 | $97.68 | -7.86% | 19 | Aug 1, 2025 | |
| INCY Incyte | Initiates: Overweight | $90 | $85.44 | +5.34% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $155 → $180 | $176.11 | +2.21% | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $450 → $490 | $489.49 | +0.10% | 26 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $300 → $450 | $482.34 | -6.70% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $185 | $184.08 | +0.50% | 23 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $1.24 | +20.97% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $15.50 | -16.13% | 21 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $215 → $225 | $199.03 | +13.05% | 40 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $245 | $247.54 | -1.03% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $120.58 | +24.40% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $55 | $47.04 | +16.92% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,325 | $1,287.79 | +2.89% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $11 → $14 | $10.58 | +32.33% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $60 | $61.36 | -2.22% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $299.69 | +16.79% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $25.63 | +75.58% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $85.70 | +28.35% | 9 | Apr 10, 2025 |
Agilent Technologies
Aug 29, 2025
Maintains: Equal-Weight
Price Target: $125
Current: $128.48
Upside: -2.71%
Natera
Aug 8, 2025
Maintains: Overweight
Price Target: $190 → $210
Current: $166.56
Upside: +26.08%
10x Genomics
Aug 8, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $13.57
Upside: +10.54%
Fortrea Holdings
Aug 7, 2025
Maintains: Underweight
Price Target: $5 → $6
Current: $10.51
Upside: -42.91%
Exact Sciences
Aug 7, 2025
Maintains: Overweight
Price Target: $65 → $55
Current: $51.41
Upside: +6.98%
Charles River Laboratories International
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $155 → $165
Current: $162.31
Upside: +1.66%
Bruker
Aug 4, 2025
Maintains: Overweight
Price Target: $46 → $43
Current: $29.79
Upside: +44.34%
Avantor
Aug 4, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $13.19
Upside: -1.44%
Illumina
Aug 1, 2025
Maintains: Underweight
Price Target: $85 → $90
Current: $97.68
Upside: -7.86%
Incyte
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $85.44
Upside: +5.34%
Jul 25, 2025
Maintains: Equal-Weight
Price Target: $155 → $180
Current: $176.11
Upside: +2.21%
Jul 24, 2025
Maintains: Equal-Weight
Price Target: $450 → $490
Current: $489.49
Upside: +0.10%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $300 → $450
Current: $482.34
Upside: -6.70%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $165 → $185
Current: $184.08
Upside: +0.50%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.24
Upside: +20.97%
Jun 24, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $15.50
Upside: -16.13%
Jun 24, 2025
Maintains: Overweight
Price Target: $215 → $225
Current: $199.03
Upside: +13.05%
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $245
Current: $247.54
Upside: -1.03%
Jun 24, 2025
Initiates: Overweight
Price Target: $150
Current: $120.58
Upside: +24.40%
Jun 24, 2025
Initiates: Overweight
Price Target: $55
Current: $47.04
Upside: +16.92%
Jun 24, 2025
Initiates: Overweight
Price Target: $1,325
Current: $1,287.79
Upside: +2.89%
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $10.58
Upside: +32.33%
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $61.36
Upside: -2.22%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $299.69
Upside: +16.79%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $25.63
Upside: +75.58%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $85.70
Upside: +28.35%